AN AMYLOID LIGAND-FREE OPTICAL RETINAL IMAGING METHOD TO PREDICT CEREBRAL AMYLOID PET STATUS
暂无分享,去创建一个
Pedro Rosa-Neto | Jean-Philippe Sylvestre | Frédéric Lesage | Claudia Chevrefils | Jean-Paul Soucy | Sulantha Mathotaarachchi | J. Soucy | Z. Nasreddine | F. Lesage | P. Rosa-Neto | A. Robillard | S. Mathotaarachchi | S. Gauthier | J. Sylvestre | C. Chevrefils | S. Beaulieu | J. Arbour | Marc‐André Rhéaume | C. Chayer | Serge Gauthier | Jean Daniel Arbour | Marc-André Rhéaume | Sylvain Beaulieu | Alain Robillard | Céline Chayer | Ziad S. Nasreddine
[1] M. Seeliger,et al. Long-Term In Vivo Imaging of Fibrillar Tau in the Retina of P 301 S Transgenic Mice , 2012 .
[2] J. Schneider,et al. National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease , 2012, Alzheimer's & Dementia.
[3] B. Hyman,et al. Absence of Alzheimer Disease Neuropathologic Changes in Eyes of Subjects With Alzheimer Disease , 2017, Journal of neuropathology and experimental neurology.
[4] Daniel L. Farkas,et al. Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model , 2011, NeuroImage.
[5] Keith L Black,et al. Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer's disease. , 2017, JCI insight.
[6] Walter Stark,et al. Beta‐Amyloid, Phospho‐Tau and Alpha‐Synuclein Deposits Similar to Those in the Brain Are Not Identified in the Eyes of Alzheimer's and Parkinson's Disease Patients , 2014, Brain pathology.